Zacks Research Issues Positive Forecast for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities researchers at Zacks Research raised their Q3 2026 EPS estimates for shares of Phibro Animal Health in a research note issued to investors on Tuesday, December 10th. Zacks Research analyst R. Department now forecasts that the company will earn $0.35 per share for the quarter, up from their previous forecast of $0.33. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share.

Other equities research analysts have also recently issued reports about the company. Barclays upped their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Bank of America increased their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 6th. Finally, JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company.

Phibro Animal Health Stock Down 5.1 %

PAHC opened at $22.67 on Friday. The firm’s fifty day moving average is $23.58 and its 200 day moving average is $20.52. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The stock has a market cap of $918.14 million, a price-to-earnings ratio of 52.72, a price-to-earnings-growth ratio of 0.62 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.12%. Phibro Animal Health’s payout ratio is 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

A number of large investors have recently made changes to their positions in PAHC. Sofinnova Investments Inc. purchased a new position in shares of Phibro Animal Health in the 2nd quarter worth $3,975,000. Acadian Asset Management LLC increased its holdings in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after purchasing an additional 42,299 shares during the period. Algert Global LLC lifted its holdings in Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after acquiring an additional 59,850 shares during the last quarter. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health during the third quarter valued at $70,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after buying an additional 42,086 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.